Greiner Bio-One Inc. Launches New Innovative CELLdisc Product For Mass Cell Culture Post author:Sam Post published:February 9, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II July 13, 2017 Roche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics July 19, 2017 Ultragenyx Stock Booms After Burosumab Continues to Impress in Phase III Study December 3, 2017
Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II July 13, 2017
Roche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics July 19, 2017